Elective percutaneous coronary intervention: The relationship between preprocedural blood glucose levels and periprocedural myocardial injury

Texas Heart Institute Journal

Volumn 40, Issue 4, 2013, Pages 410-417

  Madani, Mohsen ^a   Alizadeh, Keivan ^a   Ghazaee, Sepideh Parchami ^a   Zavarehee, Abbas ^a   Abdi, Seifollah ^a   Shakerian, Farshad ^a   Salehi, Negar ^a   Firouzi, Ata ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Biological markers blood; Blood glucose analysis; Coronary angioplasty adverse effects; Creatine kinase, MB form blood; Hyperglycemia complications; Hypoglycemia complications; Myocardial infarction; Percutaneous coronary intervention adverse effects; Prospective studies; Troponin I blood

Indexed keywords

CREATINE KINASE MB; GLUCOSE; TROPONIN I;

ADULT; ARTICLE; BARE METAL STENT; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DRUG ELUTING STENT; FEMALE; GLUCOSE BLOOD LEVEL; HEART MUSCLE INJURY; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SMOKING; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

BIOLOGICAL MARKERS/BLOOD; BLOOD GLUCOSE/ANALYSIS; CORONARY ANGIOPLASTY/ADVERSE EFFECTS; CREATINE KINASE, MB FORM/BLOOD; HYPERGLYCEMIA/COMPLICATIONS; HYPOGLYCEMIA/COMPLICATIONS; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION/ADVERSE EFFECTS; PROSPECTIVE STUDIES; TROPONIN I/BLOOD;

ANGIOPLASTY, BALLOON, CORONARY; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; CREATINE KINASE, MB FORM; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING; TIME FACTORS; TREATMENT OUTCOME; TROPONIN I;

EID: 84884915528     PISSN: 07302347     EISSN: 15266702     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Nusca A, Patti G, Marino F, Mangiacapra F, D'Ambrosio A, Di Sciascio G. Prognostic role of preprocedural glucose levels on short-and long-term outcome in patients undergoing percutaneous coronary revascularization. Catheter Cardiovasc Interv 2012; 80(3):377-84.
2. Suleiman M, Hammerman H, Boulos M, Kapeliovich MR, Suleiman A, Agmon Y, et al. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study. Circulation 2005; 111(6):754-60.
3. van der Horst IC, Nijsten MW, Vogelzang M, Zijlstra F. Persistent hyperglycemia is an independent predictor of outcome in acute myocardial infarction. Cardiovasc Diabetol 2007; 6:2.
4. Kosiborod M, Deedwania P. An overview of glycemic control in the coronary care unit with recommendations for clinical management. J Diabetes Sci Technol 2009; 3(6):1342-51.
5. Marso SP, Miller T, Rutherford BD, Gibbons RJ, Qureshi M, Kalynych A, et al. Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial). Am J Cardiol 2007; 100(2):206-10.
6. Desouza C, Salazar H, Cheong B, Murgo J, Fonseca V. Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring. Diabetes Care 2003; 26(5):1485-9.
7. Qiao Q, Hu G, Tuomilehto J, Nakagami T, Balkau B, Borch-Johnsen K, et al. Age-and sex-specific prevalence of diabetes and impaired glucose regulation in 11 Asian cohorts. Diabetes Care 2003; 26(6):1770-80.
8. Arauz-Pacheco C, Parrott MA, Raskin P. The treatment of hypertension in adult patients with diabetes. Diabetes Care 2002; 25(1):134-47.
9. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 2006; 332(7533):73-8.
10. Toth PP, Zarotsky V, Sullivan JM, Laitinen D. Dyslipidemia treatment of patients with diabetes mellitus in a US managed care plan: a retrospective database analysis. Cardiovasc Diabetol 2009; 8:26.
11. Muhlestein JB, Anderson JL, Horne BD, Lavasani F, Allen Maycock CA, Bair TL, et al. Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention. Am Heart J 2003; 146(2):351-8.
12. Alexander JH, Sparapani RA, Mahaffey KW, Deckers JW, Newby LK, Ohman EM, et al. Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation. PURSUIT Steering Committee. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. JAMA 2000; 283(3):347-53.
13. White RD, Grande P, Califf L, Palmeri ST, Califf RM, Wagner GS. Diagnostic and prognostic significance of minimally elevated creatine kinase-MB in suspected acute myocardial infarction. Am J Cardiol 1985; 55(13 Pt 1):1478-84.
14. Mathey D, Biefield W, Hanrath P, Effert S. Attempt to quantitate relation between cardiac function and infarct size in acute myocardial infarction. Br Heart J 1974; 36(3):271-9.
15. Timmer JR, Hoekstra M, Nijsten MW, van der Horst IC, Ottervanger JP, Slingerland RJ, et al. Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention. Circulation 2011; 124(6):704-11.
16. Norhammar AM, Ryden L, Malmberg K. Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care 1999; 22(11):1827-31.
17. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of inhospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002; 87(3):978-82.
18. Marfella R, Siniscalchi M, Esposito K, Sellitto A, De Fanis U, Romano C, et al. Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome. Diabetes Care 2003; 26(11): 3129-35.
19. Ceriello A. Acute hyperglycaemia: a 'new' risk factor during myocardial infarction. Eur Heart J 2005; 26(4):328-31.
20. Smit JW, Romijn JA. Acute insulin resistance in myocardial ischemia: causes and consequences. Semin Cardiothorac Vasc Anesth 2006; 10(3):215-9.
21. Shen XH, Jia SQ, Li HW. The influence of admission glucose on epicardial and microvascular flow after primary angioplasty. Chin Med J (Engl) 2006; 119(2):95-102.
22. Ishihara M, Kojima S, Sakamoto T, Asada Y, Tei C, Kimura K, et al. Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era. Am Heart J 2005; 150(4):814-20.
23. Libby P, Maroko PR, Braunwald E. The effect of hypoglycemia on myocardial ischemic injury during acute experimental coronary artery occlusion. Circulation 1975; 51(4):621-6.
24. Judson WE, Hollander W. The effects of insulin-induced hypoglycemia in patients with angina pectoris; before and after intravenous hexamethonium. Am Heart J 1956; 52(2):198-209.
25. Galassetti P, Davis SN. Effects of insulin per se on neuroendocrine and metabolic counter-regulatory responses to hypoglycaemia. Clin Sci (Lond) 2000; 99(5):351-62.
26. Wright RJ, Frier BM. Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diabetes Metab Res Rev 2008; 24(5):353-63.
27. Frier BM, Schernthaner G, Heller SR. Hypoglycemia and cardiovascular risks. Diabetes Care 2011; 34 Suppl 2:S132-7.
28. Pascual DA, Arribas JM, Tornel PL, Marin F, Oliver C, Ahumada M, et al. Preoperative statin therapy and troponin T predict early complications of coronary artery surgery. Ann Thorac Surg 2006; 81(1):78-83.
29. Harris BM, Nageh T, Marsden JT, Thomas MR, Sherwood RA. Comparison of cardiac troponin T and I and CK-MB for the detection of minor myocardial damage during interventional cardiac procedures. Ann Clin Biochem 2000; 37(Pt 6): 764-9.
30. Ege E, Dereli Y, Kurban S, Sarigul A. Atorvastatin pretreatment diminishes the levels of myocardial ischemia markers early after CABG operation: an observational study. J Cardiothorac Surg 2010; 5:60.
31. Kulik A, Ruel M. Statins and coronary artery bypass graft surgery: preoperative and postoperative efficacy and safety. Expert Opin Drug Saf 2009; 8(5):559-71.
32. Stone GW, Kandzari DE, Mehran R, Colombo A, Schwartz RS, Bailey S, et al. Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I. Circulation 2005; 112(15):2364-72.
33. Stone GW, Reifart NJ, Moussa I, Hoye A, Cox DA, Colombo A, et al. Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part II. Circulation 2005; 112(16):2530-7.
34. Locca D, Bucciarelli-Ducci C, La Manna A, Prasad S. Images in cardiovascular medicine. Percutaneous coronary intervention of chronic total occlusion with retrograde approach: follow-up by cardiac magnetic resonance imaging. Circulation 2007; 116(2):e22-4.
35. Lexis CP, van der Horst IC, Rahel BM, Lexis MA, Kampinga MA, Gu YL, et al. Impact of chronic total occlusions on markers of reperfusion, infarct size, and long-term mortality: a substudy from the TAPAS-trial. Catheter Cardiovasc Interv 2011; 77(4):484-91.
36. Korff S, Katus HA, Giannitsis E. Differential diagnosis of elevated troponins. Heart 2006; 92(7):987-93.
37. Ricciardi MJ, Davidson CJ, Gubernikoff G, Beohar N, Eckman LJ, Parker MA, Bonow RO. Troponin I elevation and cardiac events after percutaneous coronary intervention. Am Heart J 2003; 145(3):522-8.
38. La Vecchia L, Mezzena G, Zanolla L, Paccanaro M, Varotto L, Bonanno C, Ometto R. Cardiac troponin I as diagnostic and prognostic marker in severe heart failure. J Heart Lung Transplant 2000; 19(7):644-52.
39. Qadir F, Farooq S, Khan M, Hanif B, Lakhani MS. Correlation of cardiac troponin I levels (10 folds upper limit of normal) and extent of coronary artery disease in non-ST elevation myocardial infarction. J Pak Med Assoc 2010; 60(6):423-8.
40. Lee KH, Lee SR, Kang KP, Kim HJ, Lee SH, Rhee KS, et al. Periprocedural hemoglobin drop and contrast-induced nephropathy in percutaneous coronary intervention patients. Korean Circ J 2010; 40(2):68-73.